Wealthcare Capital Management’s DexCom DXCM Stock Holding History

Wealthcare Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-52	Closed	-$5K	–	238
2021 Q1	$5K	Buy	+52	New	+$4.88K	﹤0.01%	379
2020 Q1	–	Sell	-40	Closed	-$2K	–	363
2019 Q4	$2K	Buy	+40	New	+$1.9K	﹤0.01%	436
2015 Q2	–	Sell	-24	Closed	–	–	522
2015 Q1	$0	Buy	+24	New	+$363	﹤0.01%	942

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wealthcare Capital Management's DXCM Position: Q2 2021 in Review

Wealthcare Capital Management sold out of DexCom (DXCM) in Q2 2021, closing a stake of 52 shares — an estimated $5K sold.

Wealthcare Capital Management first reported a position in DXCM in Q1 2015 and held it in 3 quarters. The position peaked at $5K in Q1 2021. 728 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

Wealthcare Capital Management reported no remaining DexCom position as of Q2 2021 after selling out during the quarter.
Wealthcare Capital Management sold 52 DexCom shares in Q2 2021, an estimated $5K.
Wealthcare Capital Management first reported a position in DexCom in Q1 2015 and held it in 3 quarters.
Wealthcare Capital Management's DexCom position peaked at $5K in Q1 2021.
728 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on Wealthcare Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.